Yong Qing Cheng
Vorstandsvorsitzender bei Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Profil
Yong Qing Cheng is the Chairman & General Manager of Beijing Tri Prime Gene Pharmaceutical Co., Ltd., which he founded in 1992.
He holds an MBA from China Europe International Business School, a graduate degree from Peking Union Medical College, and an undergraduate degree from West China School of Pharmacy.
Aktive Positionen von Yong Qing Cheng
| Unternehmen | Position | Beginn |
|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Vorstandsvorsitzender | 24.09.1992 |
Ausbildung von Yong Qing Cheng
| West China School of Pharmacy | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
| China Europe International Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
 | Health Technology |
